Correction: Revisiting the oxygen reactivity index in traumatic brain injury: the complementary value of combined focal and global autoregulation monitoring

Teodor Svedung Wettervik, Erta Beqiri, Anders Hånell, Stefan Yu Bögli, Ihsane Olakorede, Xuhang Chen, Adel Helmy, Andrea Lavinio, Peter J. Hutchinson, Peter SmielewskiCritical 2025 · DOI · OpenAlex

This article provides a formal correction to the study "Revisiting the oxygen reactivity index in traumatic brain injury: the complementary value of combined focal and global autoregulation monitoring," originally published in the journal Critical Care. The update addresses a significant reporting error regarding the statistical precision of the oxygen reactivity index (ORx) in patients with traumatic brain injury (TBI).

Monitoring Cerebral Autoregulation

In the management of TBI, clinicians monitor "cerebral autoregulation"—the brain's ability to maintain steady blood flow despite changes in systemic blood pressure. Two key metrics are used to assess this function:

  1. PRx (Pressure Reactivity Index): A measure of global autoregulation.
  2. ORx (Oxygen Reactivity Index): A measure of focal autoregulation based on brain tissue oxygen levels.

The original study aimed to determine if monitoring both indices provides better prognostic value than monitoring just one. While the core finding—that ORx is independently associated with mortality—remains valid, the precision of that association was previously misrepresented in the narrative text.

The Statistical Correction

The study utilized multivariable logistic outcome regression to isolate the effect of ORx while adjusting for factors such as age, initial injury severity (Glasgow Coma Scale), and global pressure reactivity (PRx).

The correction specifically addresses the reported 95% confidence interval (CI) for the association between mean ORx and mortality:

  • Original Reported CI: [25.87–12,271.11]
  • Corrected CI: [1.82–73.67]

While the Odds Ratio (OR) of 11.3 remains unchanged, the corrected interval is much more scientifically plausible. An upper bound exceeding 12,000 typically suggests a mathematical error or an extremely unstable model. The corrected range confirms that while ORx is a significant predictor of mortality ($p=0.01$), the strength of that association falls within a standard clinical range.

Key Results and Clinical Insights

The corrected findings clarify the prognostic power of focal autoregulation monitoring in the intensive care setting:

  • Mortality Prediction: Mean ORx is independently associated with mortality. Higher (worse) ORx values significantly increase the likelihood of death, even when accounting for age and global autoregulation (PRx).
  • Favourable Outcome: Interestingly, ORx was not independently associated with "favourable outcome" (recovery). This suggests that while poor oxygen reactivity is a strong indicator of fatal brain stress, it may not be the primary driver of whether a surviving patient achieves a high level of functional recovery.

Limitations and Future Directions

The primary limitation highlighted by this correction is the remaining width of the confidence interval [1.82–73.67]. This suggests a high degree of variability in individual physiological responses or a limited sample size for the multivariable model.

Future research in this area will likely focus on validating these indices in larger, multi-center cohorts to narrow the confidence intervals and investigating why ORx predicts mortality more effectively than functional recovery. Ultimately, the goal is to develop real-time clinical decision-support tools that integrate both focal and global monitoring to guide personalized treatment in the ICU.

Summary updated

BibTeX
@inproceedings{wettervik2025correction,
  author = {Teodor Svedung Wettervik and Erta Beqiri and Anders Hånell and Stefan Yu Bögli and Ihsane Olakorede and Xuhang Chen and Adel Helmy and Andrea Lavinio and Peter J. Hutchinson and Peter Smielewski},
  title = {{Correction: Revisiting the oxygen reactivity index in traumatic brain injury: the complementary value of combined focal and global autoregulation monitoring}},
  booktitle = {Critical},
  year = {2025},
  doi = {10.1186/s13054-025-05614-1},
}
Figure